Joshua Silverman Insider Trading $AKER MyMD Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joshua Silverman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joshua Silverman. Joshua Silverman is Director in NATIONAL HOLDINGS CORP ($OLY) and Director in Protagenic Therapeutics, Inc.\new ($ATRN) and in DropCar, Inc. ($WPCS) and Director in WPCS INTERNATIONAL INC ($WPCS) and Director in TAPIMMUNE INC ($TPIV) and Director in Akers Biosciences, Inc. ($AKER) and Director in Neurotrope, Inc. ($NTRP) and Director in Synaptogenix, Inc. ($SNPX) and Director in Petros Pharmaceuticals, Inc. ($PTPI).
Joshua Silverman in MyMD Pharmaceuticals, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Joshua Silverman: Director
Holdings: 112,101 shares
Current Value: $140,126
Latest Transaction: Apr 20 2021
$AKER Market Capitalization: $6.82M
$AKER Previous Close: $1.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joshua Silverman in MyMD Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DCAR, MRKR, AKER, NHLD, NTRP, PTPI, PTIX, SNPX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Option Exercise | M | 0.00 | 109,500 | 0 | 0 | |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Payment of Exercise | F | 4.94 | 38,325 | 189,326 | 71,175 | 109.5 K to 71.2 K (-35.00 %) |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Buy | M | 0.00 | 109,500 | 0 | 112,101 | 2.6 K to 112.1 K (+4,209.92 %) |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Option Exercise | M | 0.00 | 109,500 | 0 | 0 | |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Payment of Exercise | F | 4.94 | 38,325 | 189,326 | 71,175 | 109.5 K to 71.2 K (-35.00 %) |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Buy | M | 0.00 | 109,500 | 0 | 112,101 | 2.6 K to 112.1 K (+4,209.92 %) |
| Sep 11 2020 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Option Exercise | A | 0.00 | 219,000 | 0 | 219,000 | |
| Jan 03 2020 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Option Exercise | M | 0.00 | 5,201 | 0 | 0 | |
| Jan 03 2020 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Buy | M | 0.00 | 5,201 | 0 | 5,201 | 0 to 5.2 K |
| Apr 02 2019 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Option Exercise | A | 0.00 | 124,827 | 0 | 124,827 |
Page: 1